Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment

Published: Oct 30, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, ISRAEL, Oct. 30, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it was granted a patent by the U.S. Patent and Trademark Office for its composition of Vayacog® and its use in age-associated memory impairment and mild cognitive impairment.

Help employers find you! Check out all the jobs and post your resume.

Back to news